- Home
- AMRN vs HGLB Comparison
AMRN vs HGLB Comparison
Compare AMRN & HGLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMRN | HGLB |
|---|---|---|
| Founded | 1989 | 1998 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 207.7M |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMRN | HGLB |
|---|---|---|
| Price | $13.75 | $9.23 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 87.2K | ★ 91.8K |
| Earning Date | 10-29-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.16% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $226,733,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.08 | $6.42 |
| 52 Week High | $20.90 | $9.45 |
Technical Indicators
Market Signals| Indicator | AMRN | HGLB |
|---|---|---|
| Relative Strength Index (RSI) | 32.49 | 41.86 |
| Support Level | $13.41 | $8.96 |
| Resistance Level | $14.30 | $9.39 |
| Average True Range (ATR) | 0.72 | 0.26 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 8.95 | 32.41 |
Price Performance
Historical ComparisonAbout AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About HGLB Highland Global Allocation Fund
Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.